Some analysts expect demand for ResMed's CPAP devices to be disrupted by the U.S. approval for Eli Lilly's weight-loss drug Zepbound ... according to the American Medical Association. ResMed's ...
The renowned global provider of sample and assay technologies has a market capitalization of $10.30 billion. QGEN’s earnings surpassed estimates in three of the trailing four quarters and missed on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback